Company Filing History:
Years Active: 1980
Title: Anke Bentlage: Innovator in Medicinal Chemistry
Introduction
Anke Bentlage is a prominent inventor based in Braunschweig, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on sila-substituted 1,4-dihydropyridine derivatives. Her research focuses on developing compounds that can positively influence circulation, showcasing her commitment to advancing medical science.
Latest Patents
Anke Bentlage holds a patent for her invention titled "Sila-substituted 1,4-dihydropyridine derivatives and their medicinal use." This patent outlines the utility of these derivatives as medicaments that can affect circulation. The invention also includes methods for procuring these derivatives, compositions containing them, and various methods for their application in medical treatments. She has 1 patent to her name, reflecting her innovative contributions to the field.
Career Highlights
Anke Bentlage is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. Her role at Bayer allows her to collaborate with other experts in the field and contribute to groundbreaking research and development projects. Her work is instrumental in pushing the boundaries of medicinal chemistry and improving therapeutic options for patients.
Collaborations
Anke has worked alongside notable colleagues such as Reinhold Tacke and Robertson Towart. These collaborations have enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Anke Bentlage is a trailblazer in the field of medicinal chemistry, with her innovative work on sila-substituted 1,4-dihydropyridine derivatives paving the way for new therapeutic possibilities. Her contributions to Bayer Aktiengesellschaft and her collaborations with esteemed colleagues further highlight her importance in the realm of scientific innovation.